Functional Improvements In Knee Kinematics During Walking Gait Over Six Months Following Treatment With Xt-150: Pooled Results From Two Clinical Trials

Purpose: To investigate if an intraarticular injection of a novel non-viral gene therapy delivering a proprietary version of the cytokine IL-10 (XT-150, Xalud Therapeutics, USA), improves knee function in people with symptomatic and radiographic knee osteoarthritis (OA).